Schedule 13G ownership disclosure
Spero Therapeutics Inc
Security class unavailable · CUSIP: 84833T103
Event date: 2022-09-22
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,242,965
- Percent of class
- 3.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001591986-22-000019
- Form type
- SC 13G
- Filer
- Aquilo Capital Management, LLC
- CIK
- CIK 1591986
- Filed
- Oct 03, 2022
- Reporting period
- Sep 22, 2022
- Description
- Schedule 13G beneficial ownership